Skip to main content
Signal8

Lerner Neil

SEC insider (Form 3/4/5 filer). CIK 0001505148. Chief Accounting Officer at Compass Therapeutics, Inc. (CMPX). 7 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in BOSTON, MA.

Companies Lerner Neil has filed insider reports for

  • Compass Therapeutics, Inc. (CMPX): Officer, Chief Accounting Officer
Lerner Neil profile photo

Lerner Neil

CIK: 0001505148

Transaction Breakdown

Open Market Buys (P)4 (57.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Compass Therapeutics, Inc. logo
CMPX

Compass Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Oct 1, 2026
    Purchase
    Direct
    20K shares at avg. $0.92$18K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Sep 24, 2026
    Purchase
    Direct
    2.5K shares at avg. $1.14$3K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Apr 29, 2026
    Purchase
    Direct
    15K shares at avg. $1.89$28K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Apr 29, 2026
    Award
    Direct
    15K shares at avg. $1.89$28K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Jan 2, 2026
    Award
    Direct
    62.5K shares at avg. $5.17$323K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Apr 7, 2025
    Purchase
    Direct
    20K shares at avg. $1.42$28K
  • Compass Therapeutics, Inc. logo
    CMPX

    Compass Therapeutics, Inc.

    Feb 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    200K shares-

1-7 of 7